Want to stay updated on the latest mining news?

Stay Informed – Subscribe to latest updates. We promise to send only relevant and valuable emails, just insights you care about!

Caledonia Mining Corporation Plc: Annual Report on Form

ST HELIER, Jersey , May 16, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”)  (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces that it has filed with the U.S. Securities and Exchange Commission (the “SEC”) on EDGAR the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, […]

Denarius Metals Announces Receipt of 20-Year Water Concession and Now Has All Required Permits to Re-Start Operations at the Aguablanca Project in Spain; Files First Quarter 2025 Interim Filings on SEDAR+

May 15, 2025 6:28 PM EDT | Source: Denarius Metals Corp. Toronto, Ontario–(Newsfile Corp. – May 15, 2025) – Denarius Metals Corp. (Cboe CA: DMET) (OTCQX: DNRSF) (“Denarius Metals” or “the Company”) announced today that it has filed its unaudited interim condensed consolidated financial statements and accompanying management’s discussion and analysis (MD&A) for the […]

Steppe Gold Announces Q1 2025 Financial Results

May 15, 2025 6:27 PM EDT | Source: Steppe Gold Ltd. Ulaanbaatar, Mongolia–(Newsfile Corp. – May 15, 2025) – Steppe Gold Ltd. (TSX: STGO) (OTCQX: STPGF) (FSE: 2J9) (“Steppe Gold” or the “Company“) is pleased to announce its financial results for the quarter ended March 31, 2025. HIGHLIGHTS All figures in US$000’s unless stated […]

Troilus Secures US$35 Million Loan Facility to Advance

MONTREAL, May 15, 2025 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) (“Troilus” or the “Company”) announces that it has secured a loan agreement (the “Loan Agreement”) with Auramet International, Inc. (the “Lender”) for a principal amount of up to US$35 million (~CDN$49 million) (the “Loan”). This non-dilutive facility will support Troilus’ […]

Comstock Announces Appointment of Chief Financial Officer

VIRGINIA CITY, Nev., May 15, 2025 (GLOBE NEWSWIRE) — Comstock Inc. (the “Company”) today announced that the Board of Directors has approved the appointment of Mr. Judd B. Merrill, as Chief Financial Officer of the Company and President of the Company’s wholly-owned mining subsidiary, Comstock Mining LLC, that, together with the Company’s other affiliated mining […]

Phenom Commences Drilling on Crescent Valley Gold Project, Nevada

May 15, 2025 4:02 PM EDT | Source: Phenom Resources Corp. Vancouver, British Columbia–(Newsfile Corp. – May 15, 2025) – Phenom Resources Corp. (TSXV: PHNM) (OTCQX: PHNMF) (FSE: 1PY0) (“Phenom” or the “Company”) is pleased to announce that drilling has commenced on the Company’s Crescent Valley Gold Project, 22 km (13 miles) southwest of […]

Commander Resources Announces Voting Results of Annual General and Special Meeting of Shareholders

May 15, 2025 3:29 PM EDT | Source: Commander Resources Ltd. Kelowna, British Columbia–(Newsfile Corp. – May 15, 2025) – Enduro Metals Corporation (TSXV: ENDR) (OTCQB: ENDMF) (FSE: SOG0) (“Enduro“) and Commander Resources Ltd. (TSXV: CMD) (“Commander” and together with Enduro, the “Parties“) are pleased to announce that Commander’s shareholders approved the previously announced […]

Jaguar Health Reports First Quarter 2025 Financials

The combined net Q1 2025 revenue of approximately $2.2 million for prescription and non-prescription products, including license revenue, decreased approximately 6% versus net Q1 2024 revenue of $2.4 million and 37% versus net Q4 2024 revenue of $3.5 million 

Mytesi prescription volume increased by approximately 1.8% in Q1 2025 over Q1 2024 and decreased by approximately 13.5% in Q1 2025 over Q4 2024

REMINDER: Today Jaguar to host investor webcast at 4:15 p.m. Eastern regarding Q1 2025 financials and company updates; Click here to register

Proof-of-concept (POC) results show crofelemer reduced total parenteral nutrition in patients with rare orphan diseases microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) by up to 27% and 12.5% – potential to modify disease progression in intestinal failure patients; Click here to access replay of April 30, 2025 investor webcast about results; additional POC results expected throughout 2025 for MVID and SBS-IF

FDA meeting in Q2 2025 on statistically significant results of Phase 3 OnTarget trial of crofelemer in prespecified subgroup of patients with breast cancer